Classification of Morphea (Localized Scleroderma)

Su, 1995, Morphea and morphea profunda, 895 Buckingham, 1980, Collagen accumulation by dermal fibroblast cultures of patients with linear localized scleroderma, J Rheumatol, 7, 130 O'Leary, 1930, Clinical study of 103 cases of scleroderma, Am J Med Sci, 180, 95, 10.1097/00000441-193007000-00013 Schachter, 1989, Localized scleroderma, Curr Opin Rheumatol, 1, 505, 10.1097/00002281-198901040-00015 Perry, 1982, Diseases that present as cutaneous sclerosis, Aust JDermatol, 23, 45, 10.1111/j.1440-0960.1982.tb00601.x Shono, 1991, Lichen sclerosus et atrophicus, morphea, and coexistence of both diseases, Arch Dermatol, 127, 1352, 10.1001/archderm.1991.01680080088007 Daoud, 1994, Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases, J Am Acad Dermatol, 30, 937, 10.1016/S0190-9622(94)70113-X Su, 1986, Bullous morphea profunda, Am J Dermatopathol, 8, 144, 10.1097/00000372-198604000-00009 Kornreich, 1977, Scleroderma in childhood, Arthritis Rheum, 20, 343 Dilley, 1968, Bilateral linear scleroderma en coup de sabre, Arch Dermatol, 97, 688, 10.1001/archderm.1968.01610120078012 Goldenstein-Schainberg, 1990, Childhood linear scleroderma “en coup de sabre” with uveitis, J Pediatr, 117, 581, 10.1016/S0022-3476(05)80693-6 Tang, 1986, Pseudo oculomotor palsy as the presenting sign of linear scleroderma, J Pediatr Ophthalmol Strabismus, 23, 236, 10.3928/0191-3913-19860901-09 Suttoŕp-Schulten, 1990, Linear scleroderma associated with ptosis and motility disorders, Br J Ophthalmol, 74, 694, 10.1136/bjo.74.11.694 Lehman, 1992, The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre: mistaken diagnosis or overlapping conditions? [editorial], J Rheumatol, 19, 844 Wartenberg, 1945, Progressive facial hemiatrophy, Arch Neurol Psychiatry, 54, 75, 10.1001/archneurpsyc.1945.02300080003001 Jablonska, 1979, Localized forms of scleroderma, Clin Rheum Dis, 5, 215, 10.1016/S0307-742X(21)00062-X Fry, 1992, Intracranial findings in progressive facial hemiatrophy, J Rheumatol, 19, 956 Person, 1979, Subcutaneous morphoea: a clinical study of sixteen cases, BrJ Dermatol, 100, 371, 10.1111/j.1365-2133.1979.tb01636.x Su, 1981, Morphea profunda: a new concept and a histopathologic study of 23 cases, Am J Dermatopathol, 3, 251, 10.1097/00000372-198110000-00003 Jablonska, 1975, Localized scleroderma, 277 Shulman, 1974, Diffuse fasciitis with hypergamma-globulinemia and eosinophilia: a new syndrome? [abstract], J Rheumatol, 1, 46 Michet, 1981, Eosinophilic fasciitis: report of 15 cases, Mayo Clin Proc, 56, 27 Coyle, 1980, Eosinophilic fasciitis (Shulman syndrome) in association with morphoea and systemic sclerosis, Acta Derm Vernereol (Stockh), 60, 181 Stogmann, 1977, Immunological studies in childhood scleroderma, Eur J Pediatr, 124, 223, 10.1007/BF00452114 Doyle, 1989, Eosinophilic fasciitis, Med Clin North Am, 73, 1157, 10.1016/S0025-7125(16)30625-3 Winkelmann, 1985, Localized cutaneous scleroderma, Semin Dermatol, 4, 90 Whittaker, 1989, Solitary morphoea profunda, Br J Dermatol, 120, 431, 10.1111/j.1365-2133.1989.tb04171.x Diaz-Perez, 1980, Disabling pansclerotic morphea of children, Arch Dermatol, 116, 169, 10.1001/archderm.1980.01640260045011 Christianson, 1956, Localized scleroderma: a clinical study of two hundred thirty-five cases, Arch Dermatol, 74, 629, 10.1001/archderm.1956.01550120049012 Falanga, 1986, Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities, Ann Intern Med, 104, 849, 10.7326/0003-4819-104-6-849 Uziel, 1994, Localized scleroderma in childhood: a report of 30 cases, Semin Arthritis Rheum, 23, 328, 10.1016/0049-0172(94)90028-0 Silman, 1988, An epidemio-logical study of scleroderma in the West Midlands, Br J Rheumatol, 27, 286, 10.1093/rheumatology/27.4.286 Peterson, 1995, The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993 [abstract], Arthritis Rheum, 38, S333 Harrington, 1989, An investigation into the incidence of auto-immune disorders in patients with localized morphoea, Br J Dermatol, 120, 645, 10.1111/j.1365-2133.1989.tb01350.x Winkelmann, 1982, Carpal tunnel syndrome in cutaneous connective tissue disease: generalized morphea, lichen sclerosus, fasciitis, discoid lupus erythematosus, and lupus panniculitis, J Am Acad Dermatol, 7, 94, 10.1016/S0190-9622(82)80015-7 Lakhanpal, 1988, Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases, Semin Arthritis Rheum, 17, 221, 10.1016/0049-0172(88)90008-X Greenberg, 1991, Osteolysis of the calcaneus in a child with localized scleroderma, Can Assoc Radiol J, 42, 360 Jarratt, 1979, Eosinophilic fasciitis: an early variant of scleroderma, J Am Acad Dermatol, 1, 221, 10.1016/S0190-9622(79)70013-2 Littman, 1989, Linear scleroderma: a response to neurologic injury? Report and literature review, J Rheumatol, 16, 1135 Umbert, 1978, Concurrent localized scleroderma and discoid lupus erythematosus, Arch Dermatol, 114, 1473, 10.1001/archderm.1978.01640220022005 Tuffanelli, 1966, Linear scleroderma with hemiatrophy: report of three cases associated with collagen-vascular disease, Dermatologica, 132, 51, 10.1159/000254396 Dehen, 1994, Internal involvement in localized scleroderma, Medicine, 73, 241, 10.1097/00005792-199409000-00002 Braun-Falco, 1991, 564 Sato, 1993, Antihistone antibodies in patients with localized scleroderma, Arthritis Rheum, 36, 1137, 10.1002/art.1780360815 Takehara, 1983, Anti-nuclear antibodies in localized scleroderma, Arthritis Rheum, 26, 612, 10.1002/art.1780260506 Torok, 1986, Morphoea in children, Clin Exp Dermatol, 11, 607, 10.1111/j.1365-2230.1986.tb00517.x Hulsmans, 1986, Hereditary deficiency of C2 in association with linear scleroderma'en coup de sabre', Arch Dermatol, 122, 76, 10.1001/archderm.1986.01660130080030 Fleischmajer, 1972, Generalized morphea. I. Histology of the dermis and subcutaneous tissue, Arch Dermatol, 106, 509, 10.1001/archderm.1972.01620130041010 Connolly, 1981, Direct immunoffuorescent findings in scleroderma syndromes, Acta Derm Venereol (Stockh), 61, 29 Soma, 1993, Coexistence of morphea and systemic sclerosis, Dermatology, 186, 103, 10.1159/000247317 Kahari, 1988, Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization, J Invest Dermatol, 90, 664, 10.1111/1523-1747.ep12560826 Ihn, 1994, Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma, J Am Acad Dermatol, 31, 591, 10.1016/S0190-9622(94)70221-7 Peltonen, 1990, Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization, J Invest Dermatol, 94, 365, 10.1111/1523-1747.ep12874491 Schmidt, 1982, Interleukin 1, a potential regulator of fibroblast proliferation, J Immunol, 128, 2177 Inn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-2, interleukin-4, and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res [in press] Ihn, 1994, Demonstration of interleukin 8 in serum samples of patients with localized scleroderma [letter], Arch Dermatol, 130, 1327, 10.1001/archderm.1994.01690100117021 Janin, 1994, Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases, Ann Intern Med, 120, 993, 10.7326/0003-4819-120-12-199406150-00004 Mayeno, 1990, Characterization of “peak E,” a novel amino acid associated with eosinophilia-myalgia syndrome, Science, 250, 1707, 10.1126/science.2270484 Silver, 1990, Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan, N Engl J Med, 322, 874, 10.1056/NEJM199003293221302 Burge, 1969, “Familial” scleroderma, Arch Dermatol, 99, 681, 10.1001/archderm.1969.01610240039006 Black, 1994, Genetics of scleroderma, Clin Dermatol, 12, 337, 10.1016/0738-081X(94)90286-0 Longo, 1993, Localized scleroderma after infection with Epstein-Barr virus, Clin Exp Rheumatol, 11, 681 Aberer, 1991, Borrelia burgdorferi and different types of morphea, Dermatologica, 182, 145, 10.1159/000247767 Aberer, 1987, Evidence for spirochetal origin of circumscribed scleroderma (morphea), Acta Derm Venereol (Stockh), 67, 225 Aberer, 1987, Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans, Am J Dermatopathol, 9, 374, 10.1097/00000372-198710000-00002 Granter, 1994, Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis, JAMA, 272, 1283, 10.1001/jama.1994.03520160067045 Lecerf, 1989, Borrelia burgdorferi and localized scleroderma [letter], Arch Dermatol, 125, 297, 10.1001/archderm.1989.01670140149031 Curtis, 1958, The prognosis of localized scleroderma, Arch Dermatol, 78, 749, 10.1001/archderm.1958.01560120069011 Rubin, 1948, Linear scleroderma: association with abnormalities of the spine and nervous system, Arch Dermatol Syph, 58, 1, 10.1001/archderm.1948.01520200004001 Murrell, 1993, A radical proposal for the pathogenesis of scleroderma, J Am Acad Dermatol, 28, 78, 10.1016/0190-9622(93)70014-K Neldner, 1978, Treatment of localized linear scleroderma with phenytoin, Cutis, 22, 569 Zarafonetis, 1988, Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy, Clin Exp Rheumatol, 6, 261 Binnick, 1977, Failure of dimethyl sulfoxide in the treatment of scleroderma, Arch Dermatol, 113, 1398, 10.1001/archderm.1977.01640100076013 Ayres, 1978, Is vitamin E involved in the autoimmune mechanism?, Cutis, 21, 321 Neldner, 1962, Scleroderma: an evaluation of treatment with disodium edetate, Arch Dermatol, 86, 305, 10.1001/archderm.1962.01590090047012 Jansen, 1968, Generalized scleroderma: treatment with an immuno-suppressive agent, Arch Dermatol, 97, 690, 10.1001/archderm.1968.01610120080013 Gibson, 1983, Cyclofenil treatment of scleroderma-a controlled study, Br J Rheumatol, 22, 218, 10.1093/rheumatology/22.4.218 Alarcon-Segovia, 1979, Long-term evaluation of colchicine in the treatment of scleroderma, J Rheumatol, 6, 705 Wollheim, 1989, Treatment of systemic sclerosis in 1988, Semin Arthritis Rheum, 18, 181, 10.1016/0049-0172(89)90060-7 Neuhofer, 1984, Treatment of localized scleroderma and lichen sclerosus with etretinate, Acta Derm Venereol (Stockh), 64, 171 Kahari, 1988, Interferon-alpha and interferon-gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture, Biochim Biophys Acta, 968, 45, 10.1016/0167-4889(88)90042-0 Falanga, 1990, D-penicillamine in the treatment of localized scleroderma, Arch Dermatol, 126, 609, 10.1001/archderm.1990.01670290053007 Uziel, 1994, Serum levels of soluble interleukin-2 receptor: a marker of disease activity in localized scleroderma, Arthritis Rheum, 37, 898, 10.1002/art.1780370618 Weiss, 1991, Antimalarial medications in dermatology: a review, Dermatol Clin, 9, 377, 10.1016/S0733-8635(18)30424-8 Nakahara, 1991, Repair of “coup de sabre” with tissue expander, Br J Plast Surg, 44, 575, 10.1016/0007-1226(91)90092-X Mayro, 1991, Facial reconstruction consideration in rheumatic diseases, Rheum Dis Clin North Am, 17, 943, 10.1016/S0889-857X(21)00138-1